相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article
Medicine, General & Internal
E. B. Walter et al.
Summary: A regimen of two 10-mu g doses of BNT162b2 administered 21 days apart was found to be safe, immunogenic, and efficacious in children aged 5 to 11 years.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Editorial Material
Pediatrics
Mary B. Leonard et al.
PEDIATRIC RESEARCH
(2022)
Article
Multidisciplinary Sciences
Enas A. Bsoul et al.
Summary: The majority of participants felt moderately to very safe working after the COVID-19 vaccine was made available, and more than 75% were moderately to very confident that the vaccine can protect them during the pandemic. At least 35% were moderately to very concerned about immediate and long-term side effects of the vaccine; despite the concerns, 94% received the vaccine.
Article
Environmental Sciences
Jaber S. Alqahtani et al.
Summary: This study aimed to assess the impact of the COVID-19 pandemic on sleep quality, insomnia, anxiety, stress, fatigue, and active coping in the United States. The findings showed a high prevalence of poor sleep quality and its association with insomnia and other mental and physical health issues. The study highlights the importance of prioritizing policies and public health efforts to address sleep problems.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Review
Public, Environmental & Occupational Health
Yuxuan Du et al.
Summary: The safety, immunogenicity, and efficacy of COVID-19 vaccines in the population aged 0-17 years are acceptable. More research is needed, especially in children under 3 years of age.
FRONTIERS IN PUBLIC HEALTH
(2022)
Article
Medicine, Research & Experimental
Mohammed Samannodi et al.
Summary: This study describes the incidence of post-COVID-19 conditions and possible risk factors in the Saudi population. The results indicate that a high proportion of individuals who previously had SARS-CoV-2 infection may experience long-term complications, including respiratory, neurological, psychological, and skin-related symptoms. Being female, old age, number of chronic complications, long-term medication, length of hospital stay and ICU stay, and duration of acute symptoms may be significant predictors of post-COVID-19 symptoms.
Article
Health Care Sciences & Services
Abdulelah M. Aldhahir et al.
Summary: This study found that in Saudi Arabia, only a small proportion of all physicians referred COPD patients to PR programs, primarily due to a lack of PR centers and trained staff. Most physicians prefer home-based PR programs and perceive smoking cessation as an essential component of PR.
Article
Biology
Miloslav Klugar et al.
Summary: This study focused on reporting the short-term side effects following COVID-19 vaccination among German healthcare workers, comparing mRNA-based and viral vector-based vaccines. Most side effects resolved within 1-3 days post-vaccination, indicating promising safety profiles for both vaccine types.
Article
Public, Environmental & Occupational Health
Sarah M. Bartsch et al.
Summary: During a pandemic, waiting for a vaccine with higher efficacy is not always the best choice, as it may result in more hospitalizations and costs, except for early on in the pandemic and for vaccines that prevent infection effectively.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE
(2021)
Review
Pharmacology & Pharmacy
Yvette N. Lamb
Summary: BNT162b2, a lipid nanoparticle-formulated mRNA vaccine encoding the SARS-CoV-2 spike protein, has received emergency use authorization in multiple countries for individuals aged 16 and older to prevent COVID-19.
Article
Infectious Diseases
Majid Alabdulla et al.
Summary: This study found that 20% of the population in Qatar is hesitant towards the COVID-19 vaccine, with concerns around safety and long-term side effects being the main reasons. Citizens and females were more likely to be hesitant, and personal research was identified as an important factor in increasing confidence in vaccine acceptance.
INFLUENZA AND OTHER RESPIRATORY VIRUSES
(2021)
Article
Biotechnology & Applied Microbiology
Mohammed Samannodi et al.
Summary: In Saudi Arabia, an appropriate proportion of parents are willing to vaccinate their children against COVID-19, but there are still some parents who are hesitant, mainly due to poor awareness about the vaccine's effectiveness on children. Raising public awareness of public health is key to gaining public trust in vaccination and the healthcare system.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Medicine, General & Internal
Hamad S. Alyami et al.
Summary: The study aimed to explore the impact of the COVID-19 pandemic on the psychological disposition of residents of Saudi Arabia. Findings indicated varying levels of risk for depression and anxiety among different demographic groups in the country. Policy makers and mental health providers are advised to monitor the psychological consequences during the pandemic and provide necessary support.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
(2021)
Article
Immunology
Edrous Alamer et al.
Summary: This study aimed to investigate the early side effects of the Pfizer-BioNTech (BNT162b2) mRNA vaccine in children aged 12-18 years in Saudi Arabia. Results showed that 60% of the participants reported at least one side effect, with pain or redness at the injection site, fatigue, fever, and headache being the most frequently reported. Female participants reported side effects more frequently than male participants, and side effects were more common after the second dose of the vaccine.
Article
Environmental Sciences
Abdallah Y. Naser et al.
Summary: This study found that the general public in Middle Eastern countries had moderate knowledge about COVID-19, with higher education level being an important predictor of knowledge scores. Further public education is needed, especially targeting young people, unemployed individuals, and those with lower levels of education.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2021)
Article
Health Care Sciences & Services
Hassan Alwafi et al.
Summary: Age and end-stage renal diseases have a significant impact on the mortality rate and the length of hospital stay among COVID-19 patients. Laboratory findings, signs, and symptoms are also associated with negative consequences for hospitalized COVID-19 patients.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE
(2021)
Article
Immunology
Daniella Campelo Batalha Cox Moore et al.
Summary: The survey in Brazil revealed a low vaccine hesitancy rate, with main concerns being vaccine efficacy, adverse reactions, and vaccine origin. Factors associated with vaccine hesitancy included male gender, having children, lower education level, age over 40, lower income, and living in the Central-West region. Despite concerns about the origin of the CoronaVac vaccine, overall vaccine confidence was high in Brazil.
Article
Environmental Sciences
Omaima Ibrahim Badr et al.
Summary: A retrospective case-control study conducted in Saudi Arabia found that the incidence of pulmonary embolism among hospitalized patients with COVID-19 was around 32%. Smoking history, low oxygen saturation, and higher D-dimer values were identified as important risk factors associated with a higher risk of developing pulmonary embolism.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2021)
Article
Immunology
Abdulaziz Alhazmi et al.
Summary: A study conducted in Saudi Arabia found that side effects reported after receiving Oxford-AstraZeneca and Pfizer-BioNTech vaccines are similar to those reported in clinical trials, indicating the safety of these vaccines. Most participants reported fatigue and pain at the injection site as common side effects. Further research is needed to assess the effectiveness of these vaccines in protecting against SARS-CoV-2 reinfections.
Editorial Material
Immunology
Matthew Z. Dudley et al.
Article
Multidisciplinary Sciences
Mohammed Shabrawishi et al.
Review
Immunology
Omna Sharma et al.
FRONTIERS IN IMMUNOLOGY
(2020)
Review
Immunology
Olivia Olson et al.
Article
Public, Environmental & Occupational Health
Mohammad H. Alyami et al.
FRONTIERS IN PUBLIC HEALTH
(2020)
